Arginine deprivation of ASS1-deficient cancers drives mistranslation and shared neoepitope production
Ontology highlight
ABSTRACT: Arginine biosynthesis is frequently suppressed in human cancer due to loss of argininosuccinate synthetase 1 (ASS1) expression, rendering cancer cells reliant on extracellular arginine. This observation propelled the development of systemic arginine depletion strategies, which are clinically safe but showed limited efficacy. Here, we show that in conditions of arginine scarcity, cancer cells with low ASS1 expression resort to aberrant mRNA translation in the form of ribosomal frameshifts and amino acid misincorporations. While aberrant proteins originated from most arginine codons, the predominant effect was observed at AGA. This codon-preference is caused by a selective decrease of tRNAArg(UCU) levels after arginine deprivation, which is linked to METTL1-mediated tRNA-modification. Using proteomics and immunopeptidomics, we validated that arginine shortage induces aberrant protein and neoepitope production at the endogenous level.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Pancreatic Cancer Cell Line, Adenocarcinoma Cell Line, Lung Cancer Cell Line, Cell Line Cell, Melanoma Cell Line
DISEASE(S): Adenocarcinoma,Lung Cancer,Melanoma,Pancreatic Cancer
SUBMITTER:
Onno Bleijerveld
LAB HEAD: Onno Bleijerveld
PROVIDER: PXD068912 | Pride | 2026-04-28
REPOSITORIES: Pride
ACCESS DATA